World Liberty Financial (WLFI), a DeFi project linked to the Trump family, has significantly increased its holdings of TRON (TRX), making it the third-largest asset in its portfolio.
Recent acquisitions included $7.35 million worth of TRX, part of a broader $168.4 million investment across six assets. WLFI’s total TRX holdings now stand at 30.1 million, valued at $7.58 million, following a series of transactions.
This shift is notable as WLFI had primarily focused on Ethereum-based assets like AAVE and WBTC, while also holding stablecoins. TRX purchases were made despite WLFI’s limited involvement with Solana, even as the Official Trump (TRUMP) memecoin launched on the network.
The move aligns with TRON’s recent efforts to attract U.S.-based investors, moving beyond its traditional focus on the Chinese market. While TRX has lagged behind other Layer 1 blockchains like Solana, the network holds $7.42 billion in total value locked, supported by a deflationary token model.
Meanwhile, WLFI’s token sale has gained momentum, with 22.38 billion WLFI tokens distributed out of a 25 billion goal. Despite a price drop to $0.05, interest has increased, driven partly by the success of the TRUMP token. However, WLFI’s fundraising still falls short of its ambitious $300 million target. The project continues to adapt its strategy, leveraging market trends and its expanding portfolio to solidify its position in the DeFi landscape.
The latest upgrade to Ethereum, Pectra, implemented on May 7, has begun to influence the dynamics of supply on the network.
Once a rising star in the crypto world, Pi Network is now under pressure as its token unlock schedule threatens to overwhelm market demand.
Binance is making changes to its trading roster again, this time pulling back three spot trading pairs and putting several cryptocurrencies under closer scrutiny.
In a significant move for crypto investment accessibility, Swiss asset manager 21Shares has introduced a new exchange-traded product (ETP) tied to the Cronos blockchain’s native token, CRO.